1 / 22

Phase I Update: Prevention & Education Community Outreach

Phase I Update: Prevention & Education Community Outreach. Justin Schofield Hepatitis C MCN Manager. Co-ordination Prevention Testing Treatment, Care & Support Education, training & awareness raising Surveillance and monitoring. Sep 2006 – Aug 2008 £4M new monies

moana
Download Presentation

Phase I Update: Prevention & Education Community Outreach

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Phase I Update:Prevention & EducationCommunity Outreach Justin Schofield Hepatitis C MCN Manager

  2. Co-ordination Prevention Testing Treatment, Care & Support Education, training & awareness raising Surveillance and monitoring Sep 2006 – Aug 2008 £4M new monies Initial local developments Period of national needs assessment to inform Phase II Phase I Action Plan

  3. HCV Prevention: NEX • Access to needle exchange facilities (NEX) • Glasgow • Highest number of syringes distributed by pharmacy services in Scotland. • 213 syringes per injector per annum(above national average) • Clyde • Lower numbers of syringes distributed • 57 syringes per injector per annum(lowest in Scotland)

  4. Pharmacy provision: 39 NEX pharmacy sites Average 6.2 per CH(C)P Funding BBV Prevention monies Phase I HCV Action Plan funds enabled recruitment of additional 10 pharmacies Glasgow Addiction Services provide management NEX packs contain: Needles, syringes, swabs, citric acid, cin bin, health promotion info Fixed Sites: Drug Crisis Centre: Almost 24-hr access Base 75: Health & Social work Women involved in prostitution Hunter St Health Service: Homeless health services NEX Provision: Glasgow

  5. Pharmacy provision: 10 NEX pharmacy sites 2 pre-existing 8 new funded by Phase I Action Plan monies Glasgow Addiction Services provide management Provision of NEX packs(same as Glasgow) Fixed Sites Part of wider harm reduction model Incl. wound management,BBV / pregnancy testing,HAV & HBV vaccination Lennox, Inverclyde & Greenock drug services Pick & mix provision,incl. paraphernalia NEX Provision: Clyde

  6. NEX Activity & Returns 2006/07 * * Return rate > 100% due to peoplereturning N/S collected elsewhere

  7. HCV Prevention & Education • C-Level • Voluntary sector provider, funded by Health Board • Peer education to people at risk of HCV(Community Rehabs, Prisons, Drug Services) • Training to a range of organisations • Board HCV Training & Education group • NEX training • HCV Awareness training for health & social care staff • Peer-led safer injecting interventions • NEX client survey re: paraphernalia • Outreach / backpacking pilot

  8. Phase I Update:Community Outreach Justin Schofield Hepatitis C MCN Manager

  9. Aims Provide support, information & advice to HCV infected individuals accessing addiction services. Improve the referral process. Increase access to treatment. Reduce the default rate amongst those referred for treatment (50%-70% DNA) Establish and maintain effective links between the CATs, tertiary treatment centres, voluntary sector, primary care and other addiction services. Pilot sites 4 x CATs South (Gorbals) South-East (Castlemilk) North-East (Easterhouse) West (Drumchapel) 3 x Community Rehabs South-East Alternatives New Horizon Momentum Tertiary Care 2.0 WTE Clinical Nurse Specialists 0.5 WTE clerical support Community Outreach Project

  10. Activity: Testing & Info 328 clients referred to CNS at CAT 218 attended DNA rate 33% 122 HCV test 63 (52%) chronic infection Activity: Hospital Care 50 referred to Hospital 20 appts in future 30 had appts. 19 attended DNA rate 37% Evaluation & Learning (Prof Avril Taylor) Service attracted clients Retention rate at clinic higher than in tertiary sector Difficulties in setting up and implementing service but main problems dealt with and intra-team relationships improved Majority view that service should continue Overwhelming client support for service Community Outreach Project

  11. Phase I Update:Treatment, Care & Support Dr Ray Fox Consultant in Infectious Diseases, Brownlee Centre Lead Clinician, Hepatitis C Managed Care Network

  12. National Action Plan: Phase I • Action Plan: • NHS Boards will develop and improve local community-based hepatitis C treatment, care & support services • NHSGGC Managed Care Network • Mapping of current provision • Analysis of need • Determine local priorities • Inform initial investment plans

  13. Phase I Developments • Clinical Nurse Specialists • 3 new nurses working at Brownlee, Glasgow Royal, Inverclyde Royal & Royal Alexandra hospitals • Supporting increase in clinical caseloads, including assessment and treatment • Dietetics • 1 new Dietician working across Glasgow city hospitals • Providing dietetic input to patient care • Assessing dietetic needs of people accessing HCV care services to inform future development

  14. Phase I Developments cont. • Outpatient Clinic provision • Refurbishment of Ward 7B at Gartnavel General as dedicated hepatitis C outpatient clinic space • To be shared by Gartnavel Gastroenterology and Brownlee Infectious Disease teams • Increase clinical capacity • Improve patient experience of care • Opens Autumn 2008

  15. Clinical Audit

  16. Introduction • Aims • Baseline data on current clinical activity • Publish aggregate findings and provide hospital-specific data to each treatment centre • Outcome indicators: • Sustained Viral Response (SVR)[undetectable viral RNA6 months after end of treatment] • Number patients commencing treatment • Number who completed course of treatment • Response to treatment by viral genotype

  17. Dec 06 Nov 07 May 08 Treatment SVR? 48 weeks 26 weeks Methodology • Anonymised data from local copies of ‘National Hepatitis C Clinical Database’ • All patients who commenced treatment during 2006

  18. Patient characteristics • 125 patients commenced treatment • Mean age = 39 years (range 20 to 69) • Two thirds male • 76% genotype 2 & 3, 24% genotype 1 & 4 • Three were co-infected with HIV • 10% recorded diagnosis of cirrhosis • 86% completed treatment

  19. Outcomes of treatment

  20. Increasing number of patients starting treatment

More Related